The global markets are opening up for the overall cannabis industry. Despite all of the bumps and setbacks, when will the Israeli cannabis market finally make its global debut?
Right now the question is largely a matter of not just “regulations” but also politics. Donald Trump delayed the entrance of Israel into the global market in a deal with President Benjamin Netanyahu in exchange for moving the nation’s capital to Jerusalem.
In fact, that entrance seems to have been deliberately slowed until the pending European-US pharmaceutical trade deal went into full force this July.
Now, with no more capital swaps on offer, and the U.S. entrenched first in the global trade pathways for medical cannabis at least that are opening up (certainly on the CBD side of the equation), Israel seems next up to the plate.
It is not as if Israelis in the biz do not know this. With external cultivation, production, tech development, and even stock deals on offer now in places like Canada, Eastern Europe, Africa, and the U.S., Israelis are already in the global market.
This despite those in Israel still being bound by a frustrating denial of market entry for what seems, at this point, to be a final stutter as no more excuses can be found.
Read more at internationalcbc.com